Giorgio Mosconi M.D.

Giorgio Mosconi MD, PhD is a prominent figure in the biopharmaceutical industry, currently serving as Senior Vice President at Fidia Farmaceutici Switzerland since November 2021, with a focus on innovation in healthcare solutions. Mosconi holds board positions at Arega Pharma and Dipharma SA. As Managing Director of Molecola SA since November 2014, Mosconi directs efforts in advancing biopharmaceuticals for oncology and neglected diseases. Previously, Mosconi co-founded and served as a Board Member at Formula Pharmaceuticals, now CoImmune, and held senior leadership roles at Gentium GmbH, Acureon Pharma, and Vicuron Pharmaceuticals, contributing to key developments in immuno-cancer therapy and anti-infectives. Educational credentials include a PhD in ORL Maxillo facial surgery from Università degli Studi di Milano and an MD in Medicine and surgery from the same institution.